Dementia Care in St. Louis, MO

Schedule A Tour

Donanemab: The Newest Drug in the Artillery

Eli Lilly and Company’s experimental intravenous drug donanemab may slow the cognitive decline of patients with Alzheimer’s disease, according to early clinical trial results, published in The New England Journal of Medicine on March 6th, 2021. The study...

How Dolan’s Aging-in-Place Benefits Persons with Dementia

Have you ever considered where you want to live when you get older? Your answer, most likely, is in the comfort of your own home. Almost 90% of seniors would rather age at home than in a nursing home or assisted living. As it is natural to prefer staying and aging at...